Arcadia Biosciences, Inc. (RKDA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Arcadia Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.16x | -1.15x | -0.28x | -0.42x | -1.51x | -5.41x |
| P/B Ratio | 0.65x | 1.30x | 0.30x | 0.31x | 0.71x | 0.91x |
| P/S Ratio | 0.56x | 1.60x | 0.87x | 0.88x | 3.26x | 3.14x |
| Profitability | ||||||
| Gross Margin | 36.2% | 41.3% | 51.2% | 17.8% | -28.4% | 35.3% |
| Operating Margin | -205.7% | -72.3% | -137.0% | -188.8% | -524.0% | -159.0% |
| Net Margin | -48.1% | -139.5% | -313.9% | -207.3% | -216.2% | -57.9% |
| EBITDA Margin | -202.6% | -148.6% | -128.7% | -198.8% | -408.7% | -67.7% |
| Liquidity | ||||||
| Current Ratio | 3.09x | 3.61x | 4.17x | 6.03x | 7.02x | 5.02x |
| Quick Ratio | 2.50x | 3.25x | 3.63x | 5.48x | 6.14x | 4.42x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.02x | 0.08x | 0.10x | 0.11x | 0.34x |
YoY = year-over-year change. Source: FMP..